The global
digital PCR (dPCR) and qPCR market is estimated to grow at a CAGR of
7.8% from 2014 to 2019. Although the mature markets (such as the U.S., Germany,
France, and U.K.) hold larger shares in the digital PCR (dPCR) and qPCR market,
the Asia-Pacific region is expected to grow at the highest CAGR of ~10.7% in the
forecast period. The growth of the digital PCR (dPCR) and qPCR market is driven
by factors such as growing geriatric population, technological advancements,
rising incidence of infectious diseases and genetic disorders, and increased
public-private investments, funds, and grants. However, factors such as high
cost of dPCR instruments and limitations of qPCR and dPCR techniques are
restraining the growth of this market. Attempts for adoption, implementation of
MIQE guidelines for publishing qPCR and dPCR-based research is posing a
significant challenge for the growth of the digital PCR (dPCR) and qPCR market.
In this report, the global
digital PCR (dPCR) and qPCR market has been segmented on the basis of type of
technology (real-time PCR and digital PCR), type of product (instruments,
reagents and consumables, and softwares and services), type of end-users
(research laboratories and academic institutes, pharmaceutical and biotechnology
companies, hospitals and diagnostic centers, clinical research organizations,
and forensic laboratories) applications and type of application (research,
clinical, and forensic applications). The real-time PCR (qPCR) technology market
accounted for the largest share of the global digital PCR (dPCR) and qPCR market
in 2014, followed by the digital PCR (dPCR) market. Factors such as
technological advancements in the field of qPCR, rising adoption of qPCR in
research and medical diagnosis, benefits offered by robotics in lab automation,
and increasing installation base of qPCR instruments are driving the growth of
qPCR technology market.
Geographically, North America
(comprising the U.S. and Canada) commands the largest share of 39.7% of the
global digital PCR (dPCR) and qPCR market in 2014, followed by Europe. The
digital PCR (dPCR) and qPCR market in the North America is primarily driven by
factors such as increase in public and private funding for development of qPCR
and dPCR technology, growing number of cancer patients, continuous reduction in
average cost of gene sequencing, and presence of major pharmaceutical companies
in the U.S. However, financial constraints faced by market players are limiting
the growth of the digital PCR (dPCR) and qPCR market in this region. The
Asia-Pacific region is poised to grow at the highest CAGR of 10.7% in the next
five years, owing to factors such as increasing focus of global life science
companies in emerging markets, growing public and private support to develop
novel dPCR and qPCR technologies, rise of Indian genomics market, and
strengthening cancer research in Japan.
The global digital PCR (dPCR)
and qPCR market is highly competitive with a large number of global as well as
local market players. As of 2013, the global digital PCR (dPCR) and qPCR market
was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc.
(U.S.), and F. Hoffmann-La Roche, Ltd. (Switzerland), which together accounted
for ~70% of the market. New product launches, product enhancements, and
partnerships, agreements, and collaborations are the major strategies adopted by
most of the market players to achieve growth in the global digital PCR (dPCR)
and qPCR market.
Reasons To Buy the Report:
From an insight perspective,
this research report has focused on various levels of analysis — industry
analysis (industry trends and Porter’s five force model), market share analysis
of top ten players, and company profiles, which together comprise and discuss
the basic views on the competitive landscape, emerging and high growth segments
of the qPCR and dPCR market, high-growth regions and their respective drivers,
restraints, challenges, and opportunities.
The report will enrich both
established firms as well as new entrants/smaller firms to gauge the pulse of
the market, which in turn will help the firms in garnering a greater market,
share. Firms purchasing the report could use any one or combination of the below
mentioned five strategies (market penetration, product development/innovation,
market development, market diversification, and competitive assessment) for
strengthening their market share.
The report provides
insights on the following pointers:
Market Penetration:
Comprehensive information on qPCR and dPCR products offered by the top 10
players in the global digital PCR (dPCR) and qPCR market. The report analyzes
the digital PCR (dPCR) and qPCR market by type of product, technology, end-user,
and application across key geographic region
Product
Development/Innovation: Detailed insights on upcoming qPCR and dPCR
technologies, research and development activities, and new product launches in
the global digital PCR (dPCR) and qPCR market
Market Development:
Comprehensive information about lucrative emerging markets. The report analyzes
the markets for various qPCR and dPCR products across key geographic region
Market Diversification:
Exhaustive information about new products, untapped geographies, recent
developments, and investments in the global digital PCR (dPCR) and qPCR market
Competitive Assessment:
In-depth assessment of market shares, strategies, products, distribution
networks, and manufacturing capabilities of leading players in the global
digital PCR (dPCR) and qPCR market
